Home LiteratureArticle Details
PMID: 14988564 Published · ppublish English Comment Letter

Effectively bridging the preclinical/clinical gap: the results of the ASTIN trial.

Stroke ·Vol. 35 ·No. 4 ·2004-04-00 ·Pages e81-2; author reply e81-2

Sughrue ME, Connolly ES

Abstract

暂无摘要

MeSH Terms
Acute Disease Animals Cerebrovascular Disorders/prevention & control Clinical Trials as Topic Drug Evaluation, Preclinical Glycoproteins/therapeutic use Humans Mice Neuroprotective Agents/therapeutic use Neutrophils/drug effects Rats Stroke/drug therapy
Chemicals
Glycoproteins Neuroprotective Agents UK279276
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sughrue Michael E
Connolly E Sander
Article Info
Journal
Stroke
Abbr.
Stroke
ISSN
1524-4628
DOI
10.1161/01.STR.0000121164.29117.44
Published
2004-04-00
Epub
2004-00-26
Pages
e81-2; author reply e81-2
Language
English
Region
United States
NLM ID
0235266
Subset
IM
Corrections
CommentOn
PMID: 14563972
External Links
PubMed source DOI: 10.1161/01.STR.0000121164.29117.44 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2